Replies to post #341152 on Innovation Pharmaceuticals Inc (IPIX)

[Harry Wickey]

Compassionate use,
from ipix website;
http://www.ipharminc.com/expanded-access-and-compassionate-use


"We will only consider Expanded Access/Compassionate Use if the following criteria are met:

A sufficient safety profile of an investigational drug has been determined;

if the Expanded Access / Compassionate Use will not interfere with or compromise clinical trials that could be used to support an FDA application for approval of the treatment;

and when there is an adequate supply of drug treatment for the necessary clinical trials before supplying drug treatment for Expanded Access / Compassionate Use patients.

If you are a potential patient and your physician believes you may be a candidate for an Expanded Access / Compassionate Use of one of our drugs—having already prepared the necessary documentation for submission—please ask your physician to contact us at [e-mail]. Innovation Pharmaceuticals will review and respond to Expanded Access / Compassionate Use requests within 10 days of receipt.

CONTACT US"